VRAX CIK: 1885827

Virax Biolabs Group Ltd

  • United Kingdom
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
0.05
FY23:
9.63
FY24:
4.38
FY25:
4.89
FY26:
6.83
(positive)
millions USD
FY22:
0
FY23:
0.18
FY24:
1.10
FY25:
1.53
FY26:
1.50
Total assets
Change from FY22 to FY26
millions USD
FY22:
0.05
FY23:
9.81
FY24:
5.48
FY25:
6.43
FY26:
8.32

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
1.25
FY23:
0.91
FY24:
0.17
FY25:
0.67
FY26:
0.69
(negative)
millions USD
FY22:
0
FY23:
0
FY24:
0.18
FY25:
0.29
FY26:
0.30
(positive)
Change from FY22 to FY26
millions USD
FY22:
−1.20
FY23:
8.90
FY24:
5.14
FY25:
5.46
FY26:
7.33
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
0.05
FY23:
9.81
FY24:
5.48
FY25:
6.43
FY26:
8.32

All amounts in millions USD Data source:SEC EDGAR